National Centre for Pharmacoeconomics, Dublin, Ireland.
Mult Scler. 2013 Aug;19(9):1190-6. doi: 10.1177/1352458512474860. Epub 2013 Feb 11.
Increasing use of the Quality-Adjusted Life-Year to inform resource allocation decision-making has highlighted the importance of relating clinical and health-related quality of life (HRQoL) outcomes in multiple sclerosis (MS) patients.
To investigate the relationship between the Expanded Disability Status Scale (EDSS) and HRQoL utility, using the 5-level EQ-5D (EQ-5D-5L). The discriminatory power of the EQ-5D-5L was assessed using Shannon's indices.
A linear decline in utility was observed with changes in EDSS score from 0 to 6, after which point the relationship exhibited greater variability. Mean utility values ranged from -0.22 at EDSS 9 to 0.88 at EDSS 0. We found that the discriminative capacity of the EQ-5D-5L was considerably lower for the domains self-care and anxiety/depression, compared with other health-related domains.
In its first reported use in an MS population, the EQ-5D-5L displayed good discriminatory capacity, although performance differed between the various domains of health, with evidence of a ceiling effect present in the domains of self-care and anxiety/depression. The EQ-5D-5L demonstrated a high correlation with EDSS in our MS cohort up to EDSS 6, after which point the utility valuation of severe health states exhibited much greater variability. Utility estimates from this study may be used in economic evaluations of disease-modifying therapies in MS, to inform resource-allocation decisions.
越来越多地使用质量调整生命年来为资源分配决策提供信息,突出了在多发性硬化症(MS)患者中关联临床和健康相关生活质量(HRQoL)结果的重要性。
使用 5 级 EQ-5D(EQ-5D-5L)来研究扩展残疾状况量表(EDSS)与 HRQoL 效用之间的关系。使用香农指数评估 EQ-5D-5L 的区分能力。
EDSS 评分从 0 到 6 时,效用呈线性下降,之后关系的变异性更大。EDSS 9 时的平均效用值范围从 -0.22 到 EDSS 0 时的 0.88。我们发现,与其他健康相关领域相比,EQ-5D-5L 在自我护理和焦虑/抑郁领域的区分能力要低得多。
在其首次在 MS 人群中的应用中,EQ-5D-5L 显示出良好的区分能力,尽管在健康各个领域之间存在差异,自我护理和焦虑/抑郁领域存在上限效应的证据。在我们的 MS 队列中,EQ-5D-5L 与 EDSS 的相关性高达 EDSS 6,之后严重健康状态的效用估值表现出更大的可变性。本研究的效用估计可用于 MS 疾病修饰治疗的经济评估,为资源分配决策提供信息。